Clinical trials
Influenza, Human trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 10 |
| 2007 | 14 |
| 2008 | 9 |
| 2009 | 17 |
| 2010 | 8 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
| Unknown status | 5 |
| Recruiting | 4 |
| Terminated | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 37 |
| Novartis Vaccines | 11 |
| Alachua Government Services, Inc. | 7 |
| Hoffmann-La Roche | 6 |
| Seqirus | 6 |
| Sanofi Pasteur, a Sanofi Company | 5 |
| Novartis | 4 |
| Abbott Biologicals | 3 |
| ModernaTX, Inc. | 3 |
| Charite University, Berlin, Germany | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 108 |
| Orthomyxoviridae Infections | 5 |
| Respiratory Tract Infections | 4 |
| COVID-19 | 3 |
| Infections | 3 |
| Influenza in Birds | 3 |
| Lung Diseases | 3 |
| Respiratory Tract Diseases | 3 |
| Severe Acute Respiratory Syndrome | 3 |
| Virus Diseases | 3 |
Trials
Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.